GIORGINO, FRANCESCO LIBERO
 Distribuzione geografica
Continente #
NA - Nord America 1.064
AS - Asia 114
EU - Europa 110
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.292
Nazione #
US - Stati Uniti d'America 1.062
IT - Italia 68
CN - Cina 65
SG - Singapore 41
FI - Finlandia 8
GB - Regno Unito 8
IN - India 6
DE - Germania 4
FR - Francia 4
IE - Irlanda 4
ES - Italia 3
NL - Olanda 3
SE - Svezia 3
UA - Ucraina 3
AR - Argentina 1
BO - Bolivia 1
CA - Canada 1
EU - Europa 1
LT - Lituania 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
VN - Vietnam 1
Totale 1.292
Città #
Fairfield 199
Chandler 96
Ashburn 91
Woodbridge 88
Seattle 86
Houston 80
Cambridge 78
Wilmington 61
Ann Arbor 59
Singapore 36
Santa Clara 23
San Diego 22
Beijing 16
Boardman 16
Padova 14
Medford 13
Princeton 13
Des Moines 11
Nanjing 9
Helsinki 6
Roxbury 6
Ardea 4
Arnesano 4
Dearborn 4
Dublin 4
Glassboro 4
Guangzhou 4
Kunming 4
Venice 4
Hebei 3
Jiaxing 3
Kharkiv 3
Madrid 3
Mestrino 3
Milan 3
Shenyang 3
Cusano Milanino 2
Guidizzolo 2
Haikou 2
Monza 2
Pune 2
Rome 2
Rouen 2
Tianjin 2
Altamura 1
Bandra 1
Borgosesia 1
Brendola 1
Campana 1
Capannori 1
Changsha 1
Chengdu 1
Chiswick 1
Cochabamba 1
Frankfurt am Main 1
Fuzhou 1
Groningen 1
Hangzhou 1
Helston 1
Hounslow 1
Islington 1
Jinan 1
Kilburn 1
Lanzhou 1
Lima 1
Manila 1
Martina Franca 1
Munich 1
Nanchang 1
Naples 1
Ningbo 1
Ottawa 1
Panama City 1
Piombino 1
Redwood City 1
Reggello 1
San Severo 1
Shanghai 1
Spinea 1
Taiyuan 1
Verona 1
Vicenza 1
Wuhan 1
Ziano di Fiemme 1
Totale 1.132
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 174
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 154
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 115
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly 98
Treatment intensification in patients with inadequate glycemic control on basal insulin: rationale and clinical evidence for the use of short-acting and other glucagon-like peptide-1 receptor agonists 97
Patient-reported outcomes in elderly patients with type 2 diabetes mellitus treated with dual oral therapy: a multicenter, observational study from Italy 96
Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study 94
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 92
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 91
Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly 83
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 78
Thyroid function in Klinefelter syndrome: a multicentre study from KING group 78
Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome 59
Totale 1.309
Categoria #
all - tutte 5.083
article - articoli 5.083
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 0 18 42 44 37 33 16 26
2020/2021205 4 42 11 7 8 8 5 18 27 41 27 7
2021/2022245 9 25 49 27 19 3 10 28 4 2 22 47
2022/2023194 36 25 8 17 23 21 5 25 25 0 9 0
2023/202473 2 14 15 7 5 7 3 1 0 4 3 12
2024/2025116 2 29 12 14 46 13 0 0 0 0 0 0
Totale 1.309